Original article
Efficacy and safety of empagliflozin in combination with other oral hypoglycemic agents in patients with type 2 diabetes mellitus
Eficacia y seguridad de empagliflozina en combinación con otros hipoglucemiantes orales en pacientes con diabetes mellitus tipo 2
Irene Romeraa,
, Francisco Javier Ampudia-Blascob, Antonio Pérezc, Bernat Ariñod, Egon Pfarre, Sanja Giljanovic Kisf, Ebrahim Naderalig,h
Corresponding author
a Eli Lilly and Company España, Alcobendas, Madrid, Spain
b Hospital Clínico Universitario de Valencia, Valencia, Spain
c Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
d Boehringer Ingelheim Pharma GmbH & Co., España, Sant Cugat del Vallès, Barcelona, Spain
e Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany
f Eli Lilly (Suisse) SA Representative Office, Croatia, Zagreb, Croatia
g Eli Lilly and Company, UK, Basingstoke, United Kingdom
h Faculty of Science, Liverpool Hope University, Liverpool, United Kingdom
Read
19206
Timeswas read the article
2361
Total PDF
16845
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 223 | 7 | 230 |
| 2025 11 | 972 | 90 | 1062 |
| 2025 10 | 476 | 35 | 511 |
| 2025 9 | 402 | 51 | 453 |
| 2025 8 | 456 | 26 | 482 |
| 2025 7 | 403 | 35 | 438 |
| 2025 6 | 375 | 29 | 404 |
| 2025 5 | 427 | 16 | 443 |
| 2025 4 | 360 | 12 | 372 |
| 2025 3 | 393 | 31 | 424 |
| 2025 2 | 315 | 22 | 337 |
| 2025 1 | 348 | 18 | 366 |
| 2024 12 | 198 | 14 | 212 |
| 2024 11 | 172 | 15 | 187 |
| 2024 10 | 191 | 22 | 213 |
| 2024 9 | 293 | 33 | 326 |
| 2024 8 | 225 | 21 | 246 |
| 2024 7 | 242 | 24 | 266 |
| 2024 6 | 202 | 17 | 219 |
| 2024 5 | 229 | 13 | 242 |
| 2024 4 | 202 | 25 | 227 |
| 2024 3 | 291 | 29 | 320 |
| 2024 2 | 308 | 14 | 322 |
| 2024 1 | 307 | 24 | 331 |
| 2023 12 | 253 | 26 | 279 |
| 2023 11 | 291 | 27 | 318 |
| 2023 10 | 358 | 27 | 385 |
| 2023 9 | 303 | 24 | 327 |
| 2023 8 | 316 | 12 | 328 |
| 2023 7 | 199 | 17 | 216 |
| 2023 6 | 227 | 26 | 253 |
| 2023 5 | 187 | 32 | 219 |
| 2023 4 | 165 | 22 | 187 |
| 2023 3 | 156 | 31 | 187 |
| 2023 2 | 136 | 15 | 151 |
| 2023 1 | 108 | 19 | 127 |
| 2022 12 | 200 | 30 | 230 |
| 2022 11 | 160 | 26 | 186 |
| 2022 10 | 138 | 18 | 156 |
| 2022 9 | 169 | 23 | 192 |
| 2022 8 | 177 | 34 | 211 |
| 2022 7 | 139 | 17 | 156 |
| 2022 6 | 160 | 33 | 193 |
| 2022 5 | 113 | 21 | 134 |
| 2022 4 | 133 | 29 | 162 |
| 2022 3 | 160 | 44 | 204 |
| 2022 2 | 130 | 19 | 149 |
| 2022 1 | 160 | 22 | 182 |
| 2021 12 | 123 | 21 | 144 |
| 2021 11 | 120 | 33 | 153 |
| 2021 10 | 118 | 40 | 158 |
| 2021 9 | 105 | 29 | 134 |
| 2021 8 | 92 | 20 | 112 |
| 2021 7 | 65 | 24 | 89 |
| 2021 6 | 91 | 17 | 108 |
| 2021 5 | 111 | 25 | 136 |
| 2021 4 | 264 | 111 | 375 |
| 2021 3 | 181 | 37 | 218 |
| 2021 2 | 120 | 28 | 148 |
| 2021 1 | 139 | 38 | 177 |
| 2020 12 | 132 | 30 | 162 |
| 2020 11 | 115 | 18 | 133 |
| 2020 10 | 79 | 15 | 94 |
| 2020 9 | 82 | 33 | 115 |
| 2020 8 | 98 | 23 | 121 |
| 2020 7 | 101 | 21 | 122 |
| 2020 6 | 72 | 16 | 88 |
| 2020 5 | 95 | 19 | 114 |
| 2020 4 | 76 | 31 | 107 |
| 2020 3 | 75 | 23 | 98 |
| 2020 2 | 94 | 25 | 119 |
| 2020 1 | 112 | 14 | 126 |
| 2019 12 | 149 | 28 | 177 |
| 2019 11 | 65 | 14 | 79 |
| 2019 10 | 103 | 21 | 124 |
| 2019 9 | 102 | 23 | 125 |
| 2019 8 | 71 | 20 | 91 |
| 2019 7 | 73 | 22 | 95 |
| 2019 6 | 74 | 60 | 134 |
| 2019 5 | 162 | 47 | 209 |
| 2019 4 | 63 | 9 | 72 |
| 2019 3 | 29 | 15 | 44 |
| 2019 2 | 35 | 18 | 53 |
| 2019 1 | 22 | 8 | 30 |
| 2018 12 | 15 | 4 | 19 |
| 2018 11 | 24 | 11 | 35 |
| 2018 10 | 14 | 8 | 22 |
| 2018 9 | 55 | 24 | 79 |
| 2018 8 | 45 | 8 | 53 |
| 2018 7 | 32 | 10 | 42 |
| 2018 6 | 49 | 12 | 61 |
| 2018 5 | 46 | 17 | 63 |
| 2018 4 | 35 | 6 | 41 |
| 2018 3 | 36 | 7 | 43 |
| 2018 2 | 40 | 8 | 48 |
| 2018 1 | 46 | 7 | 53 |
| 2017 12 | 54 | 9 | 63 |
| 2017 11 | 50 | 9 | 59 |
| 2017 10 | 37 | 8 | 45 |
| 2017 9 | 34 | 8 | 42 |
| 2017 8 | 38 | 4 | 42 |
| 2017 7 | 22 | 3 | 25 |
| 2017 6 | 14 | 5 | 19 |
| 2017 5 | 2 | 0 | 2 |
| 2016 12 | 1 | 0 | 1 |
Show all
